Jazz Pharmaceuticals plc Net Cash Provided by (Used in) Financing Activities in USD from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Jazz Pharmaceuticals plc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2025.
  • Jazz Pharmaceuticals plc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$813M, a 1338% decline year-over-year.
  • Jazz Pharmaceuticals plc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $20.5M.
  • Jazz Pharmaceuticals plc annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$305M, a 42.4% increase from 2022.
  • Jazz Pharmaceuticals plc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$529M, a 113% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Jazz Pharmaceuticals plc Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$813M -$757M -1338% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q1 2024 -$56.6M -$26.8M -89.8% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q1 2023 -$29.8M +$241M +89% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q1 2022 -$271M -$289M -1582% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $18.3M +$166M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 -$148M -$17.3M -13.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q1 2019 -$130M -$82.8M -174% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q1 2018 -$47.6M +$134M +73.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q1 2017 -$182M -$29.2M -19.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q1 2016 -$152M -$149M -4575% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q1 2015 -$3.26M -$501M -101% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q1 2014 $498M +$495M +15785% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q1 2013 $3.13M +$21.4M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q1 2012 -$18.2M -$15.2M -510% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07
Q1 2011 -$2.99M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08

Jazz Pharmaceuticals plc Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $20.5M +$326M Jan 1, 2024 Dec 31, 2024 10-K 2025-02-26
2023 -$305M +$224M +42.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-26
2022 -$529M -$4.5B -113% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-26
2021 $3.97B +$3.44B +652% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $528M +$822M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$294M +$185M +38.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$479M -$70M -17.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 -$409M -$950M -176% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 $541M +$755M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 -$214M -$925M -130% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $711M +$735M Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 -$23.9M -$472M -105% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-23
2012 $449M +$482M Jan 1, 2012 Dec 31, 2012 10-K 2015-02-24
2011 -$33.1M -$5.56M -20.2% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-25
2010 -$27.5M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.